Back to search

Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer

Data up to Jan 2025

Published2018
Citations223
References24

Total Citations Per Year

Abstract

References (24)

The benefits and harms of breast cancer screening: an independent review

2012 • 1,358 citations

Association analysis identifies 65 new breast cancer risk loci

2017 • 1,287 citations

Polygenic susceptibility to breast cancer and implications for prevention

2002 • 902 citations

Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States

2016 • 334 citations

Personalizing Mammography by Breast Density and Other Risk Factors for Breast Cancer: Analysis of Health Benefits and Cost-Effectiveness

2011 • 306 citations

Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase

1995 • 203 citations

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening

2011 • 156 citations

Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort study

2016 • 127 citations

Cost-Effectiveness and Harm-Benefit Analyses of Risk-Based Screening Strategies for Breast Cancer

2014 • 125 citations

Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement

2012 • 120 citations

Combined Associations of Genetic and Environmental Risk Factors: Implications for Prevention of Breast Cancer

2014 • 110 citations

Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes

2016 • 100 citations

Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium

2017 • 99 citations

Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis

2015 • 94 citations

Incorporating genomics into breast and prostate cancer screening: assessing the implications

2013 • 86 citations

Cost effectiveness of the NHS breast screening programme: life table model

2013 • 76 citations

European Guide on Quality Improvement in Comprehensive Cancer Control

2017 • 55 citations

Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK

2015 • 55 citations

Evaluation of a Stratified National Breast Screening Program in the United Kingdom: An Early Model-Based Cost-Effectiveness Analysis

2017 • 50 citations

A Reality Check for Overdiagnosis Estimates Associated With Breast Cancer Screening

2014 • 46 citations

Public interest in and acceptability of the prospect of risk-stratified screening for breast and prostate cancer

2015 • 45 citations

Stratified Cancer Screening: The Practicalities of Implementation

2013 • 45 citations

Screening Men at Increased Risk for Prostate Cancer Diagnosis: Model Estimates of Benefits and Harms

2016 • 40 citations

Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC

2015 • 39 citations

Cited By (0)

No citing papers found in database

Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast… (2018) – JAMA Oncology | Metascience Observatory Explorer